Top Tweets for #DAPTchat
Don’t miss the live webinar, Complex #HighBleedingRisk Patients in the #OnyxONE Clear Study. Led by Dr. Kandzari, Dr. Waksman, and Dr. Price. View important risk info https://t.co/sGZunoG2mk #cardiotwitter #DAPTchat
Register now! https://t.co/BMnvMJpgLh

Join a live webinar as esteemed panelists discuss Complex #HighBleedingRisk Patients in the #OnyxONE Clear Study. January 28. View important risk info: https://t.co/acKYhpfkHp #PCI #cardiotwitter #DAPTchat
Register now! https://t.co/IOjFqUwVTP
Interact with Dr. Kandzari, Dr. Waksman, and Dr. Price as they review complex #highbleedingrisk patients from the #OnyxONE Clear Study. View important risk info: https://t.co/fHgNfYvCZA #PCI #cardiotwitter #DAPTchat
Register now. https://t.co/wQyxUcQCLD

Join a live webinar as esteemed panelists discuss Complex #HighBleedingRisk Patients in the #OnyxONE Clear Study. January 28. View important risk info: https://t.co/9RnJ7Uid9a #PCI #cardiotwitter #DAPTchat
Register now! https://t.co/AprZ0L8oXN
Watch as Dr. Kandzari, Dr. Waksman, and Dr. Price review a complex #PCI case and review #OnyxONE Clear Analysis results. Live on January 28. View important risk info https://t.co/acKYhpfkHp #PCI #cardiotwitter #DAPTchat
Register now!

Review #DAPT Considerations in #HighBleedingRisk Patients, featuring Dr. Price and Dr. Latib. View important risk info: https://t.co/fwhBO3IQaQ #PCI #cardiotwitter #DAPTchat
Watch the recording now. https://t.co/G0EoQ6ojzR
Watch as Dr. Kandzari, Dr. Waksman, and Dr. Price review a complex #PCI case and review #OnyxONE Clear Analysis results. Live on January 28. View important risk info https://t.co/hpEq3Ek3OE #PCI #cardiotwitter #DAPTchat
Register now! https://t.co/R499fEYLPS

Assess methods to individualize #DAPT in your #HighBleedingRisk (HBR) patients during a recorded webinar featuring Dr. Price and Dr. Latib. View important risk info: https://t.co/gxkJiLP6IG #PCI #cardiotwitter #DAPTchat
Watch the recording now. https://t.co/UXaXNeDy8J

Join panelists Dr. Kandzari, Dr. Waksman, and Dr. Price as they discuss complex #highbleedingrisk patients from the #OnyxONE Clear Study. View important risk info https://t.co/mWkY1gZX7h #PCI #cardiotwitter #DAPTchat
Register now. https://t.co/CpbcU8OqA1
Attend a live webinar with Dr. Kandzari, Dr. Waksman, and Dr. Price — Complex #HighBleedingRisk Patients in the #OnyxONE Clear Study. View important risk info https://t.co/tgfNttcrCf #PCI #cardiotwitter #DAPTchat
Register now. https://t.co/brzQkCXLdn
Attend a live webinar with Dr. Kandzari, Dr. Waksman, and Dr. Price — Complex #HighBleedingRisk Patients in the #OnyxONE Clear Study. View important risk info https://t.co/acKYhpfkHp #PCI #cardiotwitter #DAPTchat
Register now.
Attend a live webinar with Dr. Kandzari, Dr. Waksman, and Dr. Price — Complex #HighBleedingRisk Patients in the #OnyxONE Clear Study. View important risk info https://t.co/OrJjtYSJAp #PCI #cardiotwitter #DAPTchat
Register now. https://t.co/3AsNlZIh75

Did you miss the live webinar, #DAPT Considerations in #HighBleedingRisk Patients with Dr. Price and Dr. Latib? A recording is now available. View important risk info: https://t.co/F1gli37FqM
Watch the recording now. #PCI #cardiotwitter #DAPTchat https://t.co/tDA78Bb5oa
Watch the latest webinar, #DAPT Considerations in #HighBleedingRisk Patients featuring Dr. Price & Dr. Latib. View important risk info: https://t.co/fE8XONGJhF
Watch the video now! #PCI #cardiotwitter #DAPTchat https://t.co/cLeQWltccG

Don’t miss the live webinar with Dr. Price and Dr. Latib as they discuss #DAPT considerations in #HighBleedingRisk patients. View important risk info: https://t.co/mZoKT54bmB
#cardiotwitter #DAPTchat https://t.co/aeOMombkvg

Don’t miss the live webinar with Dr. Price and Dr. Latib as they discuss #DAPT considerations in #HighBleedingRisk patients. View important risk info https://t.co/acKYhpfkHp #cardiotwitter #DAPTchat https://t.co/25iLzbqDJx

Register for the webinar, #DAPT Considerations in #HighBleedingRisk Patients to engage with Dr. Price and Dr. Latib LIVE on November 5. View important risk info: https://t.co/RQPdhOix4m
#PCI #cardiotwitter #DAPTchat https://t.co/6c0VDLUDrD
Assess methods to individualize #DAPT in your #HighBleedingRisk (HBR) patients during a live webinar with Dr. Price and Dr. Latib. View important risk info: https://t.co/CLQn30bxgO
#PCI #cardiotwitter #DAPTchat https://t.co/SF250cpeNj
Assess methods to individualize #DAPT in your #HighBleedingRisk (HBR) patients during a live webinar with Dr. Price and Dr. Latib. View important risk info: https://t.co/acKYhpfkHp #PCI #cardiotwitter #DAPTchat https://t.co/25iLzbqDJx
Dr. Price and Dr. Latib will discuss #DAPT Considerations in #HighBleedingRisk Patients in a live, 60-min webinar, Nov. 5. View important risk info: https://t.co/FMN5iHH6RE
Register now! #PCI #cardiotwitter #DAPTchat https://t.co/2YKiRBEIS0

Last Seen Hashtags on Sotwe
tekerkek
Seen from Turkey
madoumedia
Seen from Indonesia
aydınmerkez
Seen from Turkey
CárcelDeTinieblas
Seen from United States
รับงานหลังสวนชุมพร
Seen from Thailand
groupSex
Seen from Turkey
GazaNazi
Seen from United States
贞操锁
Seen from United States
葬送のフリーレン
Seen from Japan
ElFito
Seen from Korea
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
241M followers

Barack Obama 
@barackobama
119.2M followers

Cristiano Ronaldo 
@cristiano
111.9M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.2M followers

KATY PERRY 
@katyperry
88.4M followers

Taylor Swift 
@taylorswift13
82.3M followers

Lady Gaga 
@ladygaga
73.8M followers

Virat Kohli 
@imvkohli
71.1M followers

Kim Kardashian 
@kimkardashian
70.1M followers

YouTube 
@youtube
68.7M followers

Bill Gates 
@billgates
64.3M followers

Neymar Jr 
@neymarjr
63.9M followers

The Ellen Show
@theellenshow
62.4M followers

CNN 
@cnn
61.8M followers

Selena Gomez 
@selenagomez
61.5M followers

X 
@x
60.8M followers


